Our laboratory seeks to understand the molecular architecture of primary brain tumors and brain metastasis. By fundamentally employing mass spectrometry-based proteomics and phosphoproteomics, we dissect the global proteomic landscapes and aberrant PTM signaling pathways that sustain tumor survival, invasion, and microenvironmental adaptation. Our ultimate objective is to translate these large-scale biochemical insights into the identification of novel therapeutic targets and predictive biomarkers, paving the way for more effective, precision-guided treatments for cancer patients.
University of Salamanca
Salamanca, Castille-Leon, Spain
Biochemistry and Molecular Biology
Post Doctoral Researcher
Queen Mary University of London, London, UK
27 Apr 2015 - 26 Nov 2021